Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma, Ewing × olaparib × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 16 Fallopian Tube Neoplasms 12 Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Neoplasms 4 Endometrial Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Glioblastoma 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Pheochromocytoma 1 Pathologic Complete Response 1 Paraganglioma 1 Osteosarcoma 1 Inflammatory Breast Neoplasms 1 High Grade Serous Carcinoma 1

Interventions

Temozolomide 7 Vincristine 5 Irinotecan 5 Cyclophosphamide 4 Etoposide 3 etoposide phosphate 2 cabozantinib 2 abemaciclib 2 Ifosfamide 2 Doxorubicin 2 silmitasertib 1 romiplostim 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 liposomal doxorubicin 1 ganitumab 1 fludarabine 1 dinutuximab 1 Zoledronic Acid 1 X-Rays 1 Whole-Body Irradiation 1 Weight-Bearing 1 Topotecan 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1 Range of Motion, Articular 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡